Radanamycin, a macrocyclic chimera of radicicol and geldanamycin
Authors:
- Gang ShenGSGang Shen
- Brian S.J. BlaggBBBrian S.J. Blagg
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (9) , 2459-2462
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Development and optimization of a useful assay for determining Hsp90’s inherent ATPase activityBioorganic & Medicinal Chemistry, 2006
- Hsp90 Inhibitors Identified from a Library of Novobiocin AnaloguesJournal of the American Chemical Society, 2005
- The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Radester, a Novel Inhibitor of the Hsp90 Protein Folding MachineryOrganic Letters, 2005
- Structures of the N-Terminal and Middle Domains of E. coli Hsp90 and Conformation Changes upon ADP BindingStructure, 2005
- Design, Synthesis, and Evaluation of a Radicicol and Geldanamycin Chimera, RadamideOrganic Letters, 2004
- Hsp90: the vulnerable chaperoneDrug Discovery Today, 2004
- Geldanamycin Leads to Superoxide Formation by Enzymatic and Non-enzymatic Redox CyclingJournal of Biological Chemistry, 2002
- A Nucleotide-dependent Molecular Switch Controls ATP Binding at the C-terminal Domain of Hsp90Journal of Biological Chemistry, 2002
- Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and GeldanamycinJournal of Medicinal Chemistry, 1999